Injury to the cardiovascular system causes an elevated expression of endoth
elin-1 (ET-1) and activation of several important signaling pathways includ
ing the mitogen-activated kinase (MAPK) cascade. The activation of these pa
thways has been implicated in the pathogenesis of cardiovascular disease ca
used by hypoxia, infections, and ischemia /reperfusion injury, cardiomyopat
hy and restenosis after balloon angioplasty. Important downstream targets o
f the MAPK and ET-1 pathways are the cell cycle regulatory molecules (cycli
ns, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors). Regu
lation of these molecules contributes to remodeling throughout the cardiova
scular system. In addition, cell cycle molecules are important in the regul
ation of angiogenesis. These new data have led to the development of potent
ial therapeutic modalities targeting these regulatory molecules in order to
ameliorate various cardiovascular disease states.